Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bloomin' Brands, Inc. Director's Dealing 2018

Jun 19, 2018

32623_dirs_2018-06-19_fe2e155e-eeca-44dd-b9f9-78385b7d4836.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bloomin' Brands, Inc. (BLMN)
CIK: 0001546417
Period of Report: 2018-06-15

Reporting Person: SMITH ELIZABETH A (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-06-15 Common Stock M 100000 $6.50 Acquired 244152 Direct
2018-06-15 Common Stock S 100000 $22.18 Disposed 144152 Direct
2018-06-18 Common Stock M 100000 $6.50 Acquired 244152 Direct
2018-06-18 Common Stock S 100000 $22.38 Disposed 144152 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-06-15 Stock Option (right to buy) $6.5 M 100000 Disposed 2019-11-16 Common Stock (100000.0) Direct
2018-06-18 Stock Option (right to buy) $6.5 M 100000 Disposed 2019-11-16 Common Stock (100000.0) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Units $0.0 Common Stock (79296.0) 79296 Direct
Restricted Stock Units $0.0 Common Stock (84165.0) 84165 Direct
Restricted Stock Units $0.0 Common Stock (56005.0) 56005 Direct
Stock Option (right to buy) $24.1 2028-02-23 Common Stock (185695.0) 185695 Direct
Stock Option (right to buy) $17.27 2027-02-24 Common Stock (267327.0) 267327 Direct
Stock Option (right to buy) $17.15 2026-02-25 Common Stock (261122.0) 261122 Direct
Stock Option (right to buy) $25.36 2025-02-26 Common Stock (220589.0) 220589 Direct
Stock Option (right to buy) $25.32 2024-02-27 Common Stock (177940.0) 177940 Direct
Stock Option (right to buy) $10.03 2021-07-01 Common Stock (550000.0) 550000 Direct

Footnotes

F1: This transaction was effected by the reporting person pursuant to a Rule 10b5-1 trading plan that was entered into on May 11, 2018.

F2: Price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $22.00 to $22.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price.

F3: Price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $22.20 to $22.60. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price.

F4: These stock options are fully vested.

F5: Each restricted stock unit represents the contingent right to receive one share of common stock of the issuer upon vesting of the unit.

F6: These restricted stock units, in the original grant amount of 79,296, will begin vesting in four equal annual installments on February 23, 2019.

F7: This field is not applicable.

F8: These restricted stock units, in the original grant amount of 112,220, began vesting in four equal annual installments on February 24, 2018.

F9: These restricted stock units, in the original grant amount of 112,010, began vesting in four equal annual installments on February 25, 2017.

F10: These stock options, in the original grant amount of 185,695 will begin vesting in four equal annual installments on February 23, 2019.

F11: These stock options, in the original grant amount of 267,327, began vesting in four equal annual installments on February 24, 2018.

F12: These stock options, in the original grant amount of 261,122, began vesting in four equal annual installments on February 25, 2017.

F13: These stock options, in the original grant amount of 220,589, began vesting in four equal annual installments on February 26, 2016.